For citations:
Shestakova M.V., Shamkhalova M.Sh., Galstyan G.R., Ruyatkina L.A., Suplotova L.A. Oral semaglutide: the innovation in type 2 diabetes management. Diabetes mellitus. 2021;24(3):273-281. (In Russ.) https://doi.org/10.14341/DM12790
Views PDF (Rus): 0
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
